Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare...
cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 07, 2021 8:34am
Cannabis Stocks Bottom
The news, short squeeze on Friday from 3:17pm lifting the whole Cannabis Sector will likely continue Monday along with US MSOS earnings all week. What's good for the sector will hopefully boost
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 07, 2021 3:40am
Cannabinoid Research Lab
https://www.thedenverchannel.com/news/national/new-cannabinoid-lab-could-be-game-changer-for-future-medical-research
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 05, 2021 11:49pm
Medical Cannabis Oncology
https://www.onclive.com/view/a-primer-on-rising-medical-cannabis-use-in-oncology
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 03, 2021 7:56am
PCT Filing
https://seekingalpha.com/news/3763784-inmed-files-pct-patent-application-for-treating-neurodegenerative-disease
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 01, 2021 5:12pm
Ginkgo
https://www.streetinsider.com/dr/news.php?id=19137819&gfv=1
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 31, 2021 9:15am
Rare cannabinoid market picking up
https://youtu.be/RgW965D4IqE
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 29, 2021 1:54pm
THCV Please
Type 2 diabetes and weight control: https://www.westword.com/marijuana/marijuana-edibles-makers-dabbling-thcv-weight-control-products-12592435
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 29, 2021 7:14am
Big Pharma Canabinoids Prescriptions
Time for big pharma to get onboard with cannabinoid medicine. https://www.karger.com/Article/FullText/512342
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 27, 2021 10:48pm
Lygos
https://www.businesswire.com/news/home/20211027005178/en/Lygos-Successfully-Completes-Commercial-Scale-Fermentation-Campaign-to-Meet-Growing-Demand-for-Bio-based-Cannabinoids
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 24, 2021 11:36am
Cannabinoid Manufacturing
Raymond James has projected $10Bin cannabinoid manufacturing by 2025. Up to $115B by 2040. Even if Inmed captures just 1% of that $10B in manufacturing that's $100M. With leading scalability, and
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 23, 2021 12:02am
Hyasynth
https://uk.investing.com/analysis/hyasynth-biologicals-patent-for-efficient-cannabinoid-production-200500188
(35)
•••
gainwidpatience
X
View Profile
View Bullboard History
Post by
gainwidpatience
on Oct 22, 2021 11:22am
Discord pumpers!
These pumpers seems to have left the building! This stock has become just a joke! Unless the board does same like Hexo by firing the CEO and mgmt, it doesn't seems to prosper imo.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 21, 2021 7:46pm
Cronos New CBG Product
https://www.globenewswire.com/news-release/2021/10/20/2317144/0/en/Cronos-Group-Launches-its-First-Cultured-Cannabinoid-Product-SPINACH-FEELZ-Chill-Bliss-2-1-THC-CBG-Gummy.html
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 20, 2021 8:46pm
Turning Point
https://finviz.com/quote.ashx?t=INM
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 20, 2021 6:29pm
Dale Report InMed
https://youtu.be/i7nlfnWlpPs
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario